TNFRSF10B and neoplasm: For instance, in the case of RO7386, a 2:2 BsAb targeting FAP and DR5 using high-affinity bivalent FAP arms ensured tumor-selective targeting, whereas bivalent low-affinity DR5 arms facilitated DR5 hyperclustering and killing of tumor cells (Brunker et al. 2016).